Subha Madhavan
Titre
Citée par
Citée par
Année
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas Research Network
Nature 455 (7216), 1061, 2008
56162008
Integrated proteogenomic characterization of human high-grade serous ovarian cancer
H Zhang, T Liu, Z Zhang, SH Payne, B Zhang, JE McDermott, JY Zhou, ...
Cell 166 (3), 755-765, 2016
5442016
A community effort to assess and improve drug sensitivity prediction algorithms
JC Costello, LM Heiser, E Georgii, M Gönen, MP Menden, NJ Wang, ...
Nature biotechnology 32 (12), 1202-1212, 2014
5372014
Rembrandt: helping personalized medicine become a reality through integrative translational research
S Madhavan, JC Zenklusen, Y Kotliarov, H Sahni, HA Fine, K Buetow
Molecular cancer research 7 (2), 157-167, 2009
3392009
Proteogenomic analysis of human colon cancer reveals new therapeutic opportunities
S Vasaikar, C Huang, X Wang, VA Petyuk, SR Savage, B Wen, Y Dou, ...
Cell 177 (4), 1035-1049. e19, 2019
1652019
Predicting new indications for approved drugs using a proteochemometric method
S Dakshanamurthy, NT Issa, S Assefnia, A Seshasayee, OJ Peters, ...
Journal of medicinal chemistry 55 (15), 6832-6848, 2012
1312012
The CPTAC data portal: a resource for cancer proteomics research
NJ Edwards, M Oberti, RR Thangudu, S Cai, PB McGarvey, S Jacob, ...
Journal of proteome research 14 (6), 2707-2713, 2015
1222015
Molecular profiling of patients with pancreatic cancer: initial results from the know your tumor initiative
MJ Pishvaian, RJ Bender, D Halverson, L Rahib, AE Hendifar, S Mikhail, ...
Clinical Cancer Research 24 (20), 5018-5027, 2018
902018
Vibration based damage detection of rotor blades in a gas turbine engine
S Madhavan, R Jain, C Sujatha, AS Sekhar
Engineering Failure Analysis 46, 26-39, 2014
842014
Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial
MJ Pishvaian, EM Blais, JR Brody, E Lyons, P DeArbeloa, A Hendifar, ...
The Lancet Oncology 21 (4), 508-518, 2020
772020
NCI workshop report: clinical and computational requirements for correlating imaging phenotypes with genomics signatures
R Colen, I Foster, R Gatenby, ME Giger, R Gillies, D Gutman, M Heller, ...
Translational oncology 7 (5), 556-569, 2014
712014
An informatics research agenda to support precision medicine: seven key areas
JD Tenenbaum, P Avillach, M Benham-Hutchins, MK Breitenstein, ...
Journal of the American Medical Informatics Association 23 (4), 791-795, 2016
702016
G-DOC: a systems medicine platform for personalized oncology
S Madhavan, Y Gusev, M Harris, DM Tanenbaum, R Gauba, ...
Neoplasia 13 (9), 771-783, 2011
612011
Recurrence of early stage colon cancer predicted by expression pattern of circulating microRNAs
N Shivapurkar, LM Weiner, JL Marshall, S Madhavan, AD Mays, H Juhl, ...
PloS one 9 (1), e84686, 2014
602014
A pilot study evaluating concordance between blood-based and patient-matched tumor molecular testing within pancreatic cancer patients participating in the Know Your Tumor (KYT …
MJ Pishvaian, RJ Bender, LM Matrisian, L Rahib, A Hendifar, WA Hoos, ...
Oncotarget 8 (48), 83446, 2017
502017
Distinct lymphocyte antigens 6 (Ly6) family members Ly6D, Ly6E, Ly6K and Ly6H drive tumorigenesis and clinical outcome
L Luo, P McGarvey, S Madhavan, R Kumar, Y Gusev, G Upadhyay
Oncotarget 7 (10), 11165, 2016
502016
The REMBRANDT study, a large collection of genomic data from brain cancer patients
Y Gusev, K Bhuvaneshwar, L Song, JC Zenklusen, H Fine, S Madhavan
Scientific data 5 (1), 1-9, 2018
492018
Somatic cancer variant curation and harmonization through consensus minimum variant level data
DI Ritter, S Roychowdhury, A Roy, S Rao, MJ Landrum, D Sonkin, ...
Genome medicine 8 (1), 1-9, 2016
492016
Ly6E/K signaling to TGFβ promotes breast cancer progression, immune escape, and drug resistance
M AlHossiny, L Luo, WR Frazier, N Steiner, Y Gusev, B Kallakury, ...
Cancer research 76 (11), 3376-3386, 2016
492016
ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer
S Madhavan, Y Gusev, S Singh, RB Riggins
Journal of experimental & clinical cancer research 34 (1), 1-8, 2015
492015
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20